C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.
Myocardial infarction in humans provokes an acute phase response, and C-reactive protein (CRP), the classical acute phase plasma protein, is deposited together with complement within the infarct. The peak plasma CRP value is strongly associated with postinfarct morbidity and mortality. Human CRP binds to damaged cells and activates complement, but rat CRP does not activate complement. Here we show that injection of human CRP into rats after ligation of the coronary artery reproducibly enhanced infarct size by approximately 40%. In vivo complement depletion, produced by cobra venom factor, completely abrogated this effect. Complement depletion also markedly reduced infarct size, even when initiated up to 2 h after coronary ligation. These observations demonstrate that human CRP and complement activation are major mediators of ischemic myocardial injury and identify them as therapeutic targets in coronary heart disease.
Griselli
M
M
Immunological Medicine Unit, Division of Medicine, Department of Histopathology, Hammersmith Hospital, London W12 ONN, United Kingdom.
Herbert
J
J
Hutchinson
W L
WL
Taylor
K M
KM
Sohail
M
M
Krausz
T
T
Pepys
M B
MB
D000208:Acute Disease; D000818:Animals; D002097:C-Reactive Protein / Q000008:administration & dosage / Q000378:metabolism*; D003167:Complement Activation; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood* / Q000473:pathology / Q000503:physiopathology; D051381:Rats
D002097:C-Reactive Protein